Onkologie. 2011:5(3):184-186

Hepatoblastoma in adult age - multimodal approach can lead to long term control - case presentation

Jiří Tomášek1, Vlastimil Válek2, Zdeněk Kala3, Tomáš Andrašina2, Štěpán Tuček1, Jana Halámková1, Jana Králová1, Antonín Krpenský4, Marta Číhalová5, Jiří Prášek6, Ondřej Bílek1, Robert Novák1
1 Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno, LF MU
2 Radiodiagnostická klinika, Fakultní nemocnice Brno, LF MU
3 Chirurgická klinika, Fakultní nemocnice Brno, LF MU
4 Patologicko-anatomický ústav FN u sv. Anny, Brno, LF MU
5 Ústav patologie, FN Brno, LF MU
6 Klinika nukleární medicíny, Fakultní nemocnice Brno, LF MU

Hepatoblastoma is the most common primary hepatic malignant tumor in children. Adult hepatoblastoma is rare and the prognosis

is poor. There are only case reports available for this diagnosis. We report a rare case of 26-year old man suffering from unresectable

hepatoblastoma successfully treated by chemotherapy, transcatheter arterial chemoembolization (TACE) and other interventional –

radiological techique for 11 years.

Keywords: adult hepatoblastoma, chemotherapy, interventional-radiology, TACE

Published: July 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tomášek J, Válek V, Kala Z, Andrašina T, Tuček Š, Halámková J, et al.. Hepatoblastoma in adult age - multimodal approach can lead to long term control - case presentation. Onkologie. 2011;5(3):184-186.
Download citation

References

  1. Nakamura S, Sho M, Kanchiro H, et al. Adult hepatoblastoma successfully treated with multimodal treatment, Langenbecks Arch Surg. 2010 Published online Apr 11. Go to original source... Go to PubMed...
  2. Remes-Troche JM, Monta?o-Loza A, Meza-Junco J, GarcíaLeiva J, Torre-Delgadillo A. Hepatoblastoma in adult age. A case report and literature review. Ann Hepatol. 2006; 5(3): 179-181. Go to original source... Go to PubMed...
  3. Bajčiová V, Štěrba J. Vliv věku na etiopatogenezu, diagnostiku a léčbu nádorů jater u dětí a adolescentů - rozdíly od hepatologie dospělého věku. Edukační sborník XXXII. Brněnské onkologické dny, Masarykův onkologický ústav, Brno, 2008: 378-380 (dostupné na: http://www.linkos.cz/odbornici/abstrakta/BOD2008_245.pdf).
  4. Ruck P, Harms D, Kaiserling E. Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation. Am J Surg Pathol. 1999; 14(9): 847-855. Go to original source... Go to PubMed...
  5. Leung TW, Patt YZ, Lau WY, Ho SK, et al. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res. 1999; 5(7): 1676-1681.
  6. Yeo W, Mok TS, Zee B, et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst. 2005; 97(20): 1532-1538. Go to original source... Go to PubMed...
  7. Kepák T, Štěrba J, Kadlecová V, Holcnerová P. Kdy pomýšlet na nádorové onemocnění u dětí? Pediatrie pro praxi 2005; 2: 76-80 (dostupné na: http://www.pediatriepropraxi.cz/artkey/ped-200502-0006.php).
  8. Kiss I, Tomášek J, Vyzula R, Sedláčková Š. Chemoterapie a konzervativní terapie nemocných s maligními ložiskovými procesy jater. In: Válek V, Kala Z, Kiss I, et al. Maligní ložiskové procesy jater, diagnostika a léčba včetně minimálně invazivních metod, Grada 2008: 321-344.
  9. Válek V, Kala Z, Kiss I, et al. Maligní ložiskové procesy jater, diagnostika a léčba včetně minimálně invazivních metod, Grada 2008: 416.




Oncology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.